Article Text
Letters
Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma
Statistics from Altmetric.com
We read with great interest the paper by Banerjee et al1 regarding the clinical outcome and response to chemotherapy in basal-like carcinoma of the breast. After extensive discussion of chemotherapeutics used in the management of basal-like carcinoma, they concluded that new treatment options should be investigated for patients with this subtype of breast cancer. A recent study by Pinilla et al2 showed that caveolin-1 (CAV1) expression is associated with a basal-like phenotype in sporadic and hereditary breast cancers. They …
Footnotes
-
Competing interests: None declared.